IBDEI39Z ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,55041,1,4,0)
 ;;=4^D05.82
 ;;^UTILITY(U,$J,358.3,55041,2)
 ;;=^5001934
 ;;^UTILITY(U,$J,358.3,55042,0)
 ;;=D05.81^^256^2775^34
 ;;^UTILITY(U,$J,358.3,55042,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55042,1,3,0)
 ;;=3^Carcinoma in Situ Right Breast,Oth Spec Type
 ;;^UTILITY(U,$J,358.3,55042,1,4,0)
 ;;=4^D05.81
 ;;^UTILITY(U,$J,358.3,55042,2)
 ;;=^5001933
 ;;^UTILITY(U,$J,358.3,55043,0)
 ;;=D05.80^^256^2775^36
 ;;^UTILITY(U,$J,358.3,55043,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55043,1,3,0)
 ;;=3^Carcinoma in Situ Unspec Breast,Oth Spec Type
 ;;^UTILITY(U,$J,358.3,55043,1,4,0)
 ;;=4^D05.80
 ;;^UTILITY(U,$J,358.3,55043,2)
 ;;=^5001932
 ;;^UTILITY(U,$J,358.3,55044,0)
 ;;=D56.8^^256^2775^182
 ;;^UTILITY(U,$J,358.3,55044,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55044,1,3,0)
 ;;=3^Thalassemias,Other
 ;;^UTILITY(U,$J,358.3,55044,1,4,0)
 ;;=4^D56.8
 ;;^UTILITY(U,$J,358.3,55044,2)
 ;;=^5002305
 ;;^UTILITY(U,$J,358.3,55045,0)
 ;;=C82.89^^256^2775^74
 ;;^UTILITY(U,$J,358.3,55045,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55045,1,3,0)
 ;;=3^Follicular Lymphoma,Extranodal/Solid Organ Sites,Other Types
 ;;^UTILITY(U,$J,358.3,55045,1,4,0)
 ;;=4^C82.89
 ;;^UTILITY(U,$J,358.3,55045,2)
 ;;=^5001540
 ;;^UTILITY(U,$J,358.3,55046,0)
 ;;=D51.8^^256^2775^189
 ;;^UTILITY(U,$J,358.3,55046,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55046,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemias,Other
 ;;^UTILITY(U,$J,358.3,55046,1,4,0)
 ;;=4^D51.8
 ;;^UTILITY(U,$J,358.3,55046,2)
 ;;=^5002288
 ;;^UTILITY(U,$J,358.3,55047,0)
 ;;=I80.9^^256^2775^174
 ;;^UTILITY(U,$J,358.3,55047,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55047,1,3,0)
 ;;=3^Phlebitis/Thrombophlebitis,Unspec Site
 ;;^UTILITY(U,$J,358.3,55047,1,4,0)
 ;;=4^I80.9
 ;;^UTILITY(U,$J,358.3,55047,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,55048,0)
 ;;=D45.^^256^2775^175
 ;;^UTILITY(U,$J,358.3,55048,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55048,1,3,0)
 ;;=3^Polycythemia Vera
 ;;^UTILITY(U,$J,358.3,55048,1,4,0)
 ;;=4^D45.
 ;;^UTILITY(U,$J,358.3,55048,2)
 ;;=^96105
 ;;^UTILITY(U,$J,358.3,55049,0)
 ;;=C77.3^^256^2775^107
 ;;^UTILITY(U,$J,358.3,55049,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55049,1,3,0)
 ;;=3^Malig Neop Axilla/Upper Limb Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,55049,1,4,0)
 ;;=4^C77.3
 ;;^UTILITY(U,$J,358.3,55049,2)
 ;;=^5001330
 ;;^UTILITY(U,$J,358.3,55050,0)
 ;;=C77.2^^256^2775^123
 ;;^UTILITY(U,$J,358.3,55050,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55050,1,3,0)
 ;;=3^Malig Neop Intra-Abdominal Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,55050,1,4,0)
 ;;=4^C77.2
 ;;^UTILITY(U,$J,358.3,55050,2)
 ;;=^267316
 ;;^UTILITY(U,$J,358.3,55051,0)
 ;;=C77.1^^256^2775^124
 ;;^UTILITY(U,$J,358.3,55051,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55051,1,3,0)
 ;;=3^Malig Neop Intrathoracic Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,55051,1,4,0)
 ;;=4^C77.1
 ;;^UTILITY(U,$J,358.3,55051,2)
 ;;=^267315
 ;;^UTILITY(U,$J,358.3,55052,0)
 ;;=C77.0^^256^2775^140
 ;;^UTILITY(U,$J,358.3,55052,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55052,1,3,0)
 ;;=3^Malig Neop Nodes of Head,Face and Neck,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,55052,1,4,0)
 ;;=4^C77.0
 ;;^UTILITY(U,$J,358.3,55052,2)
 ;;=^5001329
 ;;^UTILITY(U,$J,358.3,55053,0)
 ;;=C77.8^^256^2775^141
 ;;^UTILITY(U,$J,358.3,55053,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55053,1,3,0)
 ;;=3^Malig Neop Nodes of Multiple Regions,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,55053,1,4,0)
 ;;=4^C77.8
 ;;^UTILITY(U,$J,358.3,55053,2)
 ;;=^5001332
 ;;^UTILITY(U,$J,358.3,55054,0)
 ;;=C79.51^^256^2775^111
